相关实验视频
Updated: Jan 7, 2026

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.5K
在皮肤颗粒状疾病中使用JAK抑制剂的临床更新
Jiaxu Gu1,2, Xinglin He1,2, Bingcheng Lu1,2
1Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, China.
Frontiers in immunology
|December 29, 2025
概括
简氏激酶 (JAK) 抑制剂在治疗长期颗粒状皮肤疾病 (如沙尔科毒症) 中表现有前途. 这些向治疗有效地管理症状和改善病变,为耐火病例提供了新的希望.
科学领域:
- 皮肤病学和免疫学,专注于炎症途径.
背景情况:
- 皮肤颗粒状疾病呈现慢性,复发的过程.
- 传统疗法往往不足以控制这些疾病.
- 简氏激酶 (JAK) 信号转换器和转录激活器 (STAT) 途径对于通过关键细胞因子形成颗粒瘤至关重要.
研究的目的:
- 审查JAK抑制剂在治疗各种皮肤颗粒性疾病中的疗效.
- 综合目前关于耐火病例的JAK抑制剂的证据.
主要方法:
- 对JAK抑制剂 (托法西提尼布,鲁克索利提尼布,巴里西提尼布,乌帕达西提尼布,阿布罗西提尼布) 的临床研究和病例报告的审查.
- 专注于一些疾病,包括肉类粉症,状颗粒瘤,粒状疹和化品注射反应.
主要成果:
- 雅克抑制剂显著改善了病变结果.
- 在接受治疗的患者中观察到有效的症状控制.
- 这些向疗法显示出耐火性颗粒状疾病的潜力.
结论:
- 雅克抑制剂代表了耐火性皮肤颗粒状疾病的有前途的治疗策略.
- 需要进一步进行大规模试验,以确定最佳剂量,长期安全性以及个性化治疗的生物标志物.
相关概念视频
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Nephrotic Syndrome II : Assessment and Medical Management
179
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
179
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454
Skin Diseases and Disorders
5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
Nephrotic Syndrome I : Introduction
460
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
460
Nephrotic Syndrome III : Nursing Management
267
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
267

